MIR100HG was found significantly differentially expressed and down-regulated in CACX (53) and CACX patients with pelvic lymph node metastasis (PLNM) (21), and pathway analysis showed a significant correlation with the “cell growth and proliferation” and “cancer” phenotypes (54). This evidence concerns the gene MIR100HG and cancer.